Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

New data from the phase III PLATO study showed that ticagrelor provided greater reduction of cardiovascular events than clopidogrel in acute coronary syndromes patients undergoing planned invasive treatment (either PCI or CABG).* Although patients undergoing invasive procedures are at greater risk of bleeding, these results were achieved without a significant increase in major bleeding compared to clopidogrel.

Today in Cardiac/Hypertension...keeping you current

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

The role of pulmonary veins in atrial fibrillation
Pharmacology & Therapeutics, 11/24/09

Telmisartan prevents cardiovascular events in a broad group of at-risk patients
Expert Opinion in Pharmacotherapy, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address